Moss Adams Wealth Advisors LLC Acquires New Stake in HCA Healthcare, Inc. $HCA

Key Points

• Moss Adams Wealth Advisors LLC acquired a new stake in HCA Healthcare, purchasing 607 shares valued at approximately $233,000.
• HCA Healthcare recently reported quarterly earnings of $6.84 per share, exceeding analysts' expectations, with revenue up 6.4% year-over-year.
• The company announced a quarterly dividend of $0.72 per share, which will be paid on September 30th, representing an annual yield of 0.7%.

Moss Adams Wealth Advisors LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 607 shares of the company's stock, valued at approximately $233,000.

Other large investors also recently bought and sold shares of the company. Cheviot Value Management LLC purchased a new stake in HCA Healthcare during the 1st quarter worth about $26,000. Saudi Central Bank purchased a new position in shares of HCA Healthcare in the 1st quarter valued at about $26,000. WPG Advisers LLC purchased a new position in shares of HCA Healthcare in the 1st quarter valued at about $27,000. Atwood & Palmer Inc. purchased a new position in shares of HCA Healthcare in the 1st quarter valued at about $28,000. Finally, Bartlett & CO. Wealth Management LLC increased its holdings in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after acquiring an additional 80 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of recent analyst reports. Truist Financial increased their price objective on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. JPMorgan Chase & Co. raised their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Cantor Fitzgerald restated an "overweight" rating and set a $444.00 price target on shares of HCA Healthcare in a research note on Tuesday, August 26th. Finally, Robert W. Baird raised their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $407.75.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $421.07 on Tuesday. The company has a market cap of $98.53 billion, a price-to-earnings ratio of 17.70, a price-to-earnings-growth ratio of 1.32 and a beta of 1.41. The stock has a 50 day simple moving average of $390.93 and a 200-day simple moving average of $370.25. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $422.96. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the business posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.